Show More News: Watch more news
News search related to the stock Pfizer (ordered by date):
Pfizer Declares First-Quarter 2019 Dividend Business Wire
The board of directors of Pfizer Inc. today declared a 36-cent first-quarter 2019 dividend on the company's common stock, payable March 1, 2019, to sh.
Pfizer UK names new managing director PharmaTimes
Pfizer has announced the appointment of Ben Osborn as managing director in the UK, taking over from Erik Nordkamp, who will now become general manager ...
Pfizer Boosts Q1 Dividend, Launches $10 Billion Buyback as Read Says Farewell TheStreet.com
Pfizer shares traded lower Friday even as the pharmaceutical group boosted it latest quarterly dividend and said it would buyback another $10 million in ...
Pfizer (PFE) Raises Quarterly Dividend 5.9% to $0.36, 3.3% Yield; Authorizes New $10B Buyback StreetInsider.com
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. (Updated - December 14, 2018 12:14 PM EST).
Pfizer's cut-price version of Avastin wins EU panel greenlight Reuters
(Reuters) - A panel of European Medicines Agency (EMA) on Friday recommended approval for Pfizer Inc's Zirabev, a cheaper version to Roche Holding AG's ...
Pfizer (PFE) Commences Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) Candidate, PF-06482077 StreetInsider.com
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Pfizer Inc. (NYSE: PFE) announced today the ...
Senator to Pfizer CEO: Stop playing 'political games' with drug prices FiercePharma
Sen. Tammy Baldwin, D-Wis., blasted Pfizer's plan to increase prices in January and called on the company to release details about its manufacturing and ...
Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan Zacks.com
JP Morgan downgrades Pfizer (PFE) on assumptions that the market has discounted all growth factors for Pfizer.
JP Morgan downgrades Pfizer, saying stock has moved too far, too fast: 'Moving to the sidelines' CNBC
J.P. Morgan downgraded Pfizer shares to neutral from overweight on Tuesday, warning clients that the stock's rally will likely slow after climbing more than 22 ...
Pfizer to raise drug prices despite Trump complaints CNN
New York (CNN Business) Pfizer is planning to raise prices on 41 drugs in January, a few months after the company agreed to defer hikes under heavy pressure ...
Pfizer still unable to get on top of problems at Hospira injectables plant FiercePharma
Since Pfizer's Kansas plant received an FDA warning letter last year, the company has insisted it is making good progress on turning things around at the ...
Pfizer Lifting Prices on 41 Drugs in 2019 Investopedia
After rolling back some increases on drug prices earlier this year under pressure from President Donald Trump, pharmaceutical industry giant Pfizer Inc. (PFE) is ...
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Zacks.com
In the latest trading session, Pfizer (PFE) closed at $44.40, marking a +1.09% move from the previous day.
Pfizer strikes deal with Chinese online pharmacy Jianke pharmaphorum
Pfizer is to launch a new retail, hospital and internet healthcare strategy in China as part of a deal with local online pharmacy Jianke.
Pfizer among those seen hiking payouts next week Seeking Alpha
According to Bloomberg BDVD, three S&P 500 companies will be raising their dividend next week: Pfizer (NYSE:PFE) to $0.36 from $0.34, Fifth Third Bancorp ...
Pfizer withdraws European marketing application for Humira biosimilar Seeking Alpha
Pfizer (PFE -2.1%) has withdrawn its marketing application in Europe seeking approval for Fyzoclad, its biosimilar to AbbVie's (ABBV -1.8%) Humira ...
Pfizer Slips After JPMorgan Downgrade on Patent Cycle Concerns TheStreet.com
Pfizer shares slipped lower in pre-market trading Tuesday after analysts at JPMorgan lowered their rating for the drugmaker amid concerns of the loss of ...
Where Will Pfizer Inc. Be in 5 Years? The Motley Fool
With a little momentum at the end of 2018, Pfizer Inc. (NYSE:PFE) could be headed for its best year yet in the 21st century. The big pharma stock is absolutely ...
AbbVie, Pfizer reach licencing agreement for biosimilar Humira pharmaphorum
AbbVie has granted a patent license allowing Pfizer to sell its Humira (adalimumab) biosimilar in many countries around the world.
Report: Developing Opportunities within Pfizer, Bed Bath & Beyond, Vishay Intertechnology, Cloudera, Markel, and QTS Realty Trust ? Future Expectations, Projections Moving into 2018 Nasdaq
NEW YORK, Dec. 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for.
Pfizer to add 100 oncology R&D jobs, cut others amid restructure BioPharma Dive
Pfizer will add about 100 new jobs in oncology research and development at its La Jolla, California site, as its Cancer Immunology Discovery unit relocates out ...
Pfizer Reaches a Global Agreement with AbbVie Business Wire
Pfizer Inc. (NYSE:PFE) today announced that it has signed licensing agreements with AbbVie, resolving all global intellectual property matters for Pfi.
Stocks making the biggest moves premarket: DSW, F, GM, CVS, PFE & more CNBC
Check out the companies making headlines before the bell: DSW ? The shoe retailer reported adjusted quarterly profit of 70 cents per share, above the ...
Pfizer asks GOP Sen. Cindy Hyde-Smith for contribution refund, ex-Facebook President Sean Parker condemns hanging comment, does not request money back CNBC
Pfizer joins Walmart, AT&T, Boston Scientific, Union Pacific, and Leidos in asking for campaign contributions to be returned.
Pfizer Transfers 100 Jobs to La Jolla Oncology Site as It Closes Facility in South San Francisco BioSpace
Pfizer's La Jolla cancer research center is set to grow by about 100 people. The pharma giant is transferring employees from a recently shuttered South San ...
Pfizer Receives FDA Approval For AML Drug Seeking Alpha
Pfizer announced that it had received FDA approval for DAURISMO to treat newly diagnosed elderly patients with acute myeloid leukemia. The FDA approved ...
Pfizer Inc. (PFE) Management Presents on Evercore ISI HealthCONx Conference Call Transcript Seeking Alpha
Call Start: 08:45 Call End: 09:28 Pfizer Inc. (NYSE:PFE) Evercore ISI HealthCONx Conference Call November 29, 2018 08:45 ET Executives Chuck Triano - SVP ...
Daily Dividend Report: NLY, ABT, PFE, T, EQR Nasdaq
The Board of Directors of Annaly Capital Management declared the fourth quarter 2018 common stock cash dividend of $0.30 per common share. This.
Pfizer (PFE) Stock Moves -1.78%: What You Should Know Zacks.com
Pfizer (PFE) closed the most recent trading day at $45.17, moving -1.78% from the previous trading session.
FDA approves new blood cancer treatment from Pfizer Reuters
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a ...
Merck and Pfizer chalk up another fail for Bavencio pharmaphorum
Merck KGaA and Pfizer's late entrant to the checkpoint inhibitor category has failed a phase III trial in ovarian cancer.
Equity News: Investors Keen on Pfizer Inc. (NYSE:PFE) as it Makes Waves With Moves The Coin Guild
Major market players are buzzing over Pfizer Inc. (NYSE:PFE) as their share price hit $44.57 at the end of the most recent trading session. Market capitalization ...
Pfizer gets first FDA nod for hedgehog inhibitor in AML PMLiVE
Pfizer has added to a run of new product approvals for acute myeloid leukaemia (AML) with an FDA nod for Daurismo, the first smoothened (SMO) receptor ...
Pfizer Is in Breakout-Mode This Fall: Chart TheStreet
A classic technical breakout in shares of Pfizer points to more upside ahead in this healthcare giant....PFE.
Pfizer Gets Global Patent License for AbbVie's Humira Pharmaceutical Technology Magazine
AbbVie will grant Pfizer license to launch a biosimilar to AbbVie's Humira worldwide.
Redux And Future Potential: Pfizer Inc. (PFE), Nokia Corporation (NOK) NMSU N?ws
PFIZER INC, 10% Owner, bought 55,556 shares of the Pfizer Inc. (NYSE:PFE) in an exchange that happened on October 15th, 2018. The stock was bought at an ...
An FDA inspection report shows just how troubled a Pfizer plant really is STAT
The problems at the McPherson, Kan., facility follow Pfizer's $16 billion acquisition of Hospira.
unusual options activity bullish buying tjx companies pfizer CNBC
"Halftime Report" trader Jon Najarian spots bullish option buying in TJX Companies and Pfizer.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Chris Boshoff, senior vice president and head, Immuno.
Pfizer loses Lyrica patent fight - Latest Pharmacy News | Business | Magazine Pharmacy Business
Pfizer lost the final round in a lengthy patent battle after the Supreme Court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica, exposing the ...
Brainstorm Health: HIV Prevention Pill, Pfizer Price Hikes, Chickenpox Outbreak Fortune
Greetings, readers! On Tuesday, the U.S. Preventive Services Task Force (USPSTF), the government body tasked with, well, recommending preventive health ...
Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer GlobeNewswire
Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019. CALGARY, Alberta, Nov.
On a roll with FDA approvals, Pfizer doubles down in AML with Daurismo nod FiercePharma
Make that four drug approvals for Pfizer's oncology unit in less than two months. In a welcome streak for the pharma giant?what with Lyrica generics ...
Kentucky Retirement Systems Increases Position in Dollar Tree (DLTR); As Pfizer (PFE) Shares Rose, Private Asset Management Lowered Position by $729,300 The FinExaminer
Kentucky Retirement Systems increased its stake in Dollar Tree Inc (DLTR) by 70.19% based on its latest 2018Q3 regulatory filing with the SEC. Kentucky ...
Pfizer McPherson site hit with US FDA repeat observations In-PharmaTechnologist.com
Pfizer's sterile drug manufacturing site in Kansas received eight observations during an FDA inspection. Following its acquisition of Hospira in 2015, Pfizer has ...
China's online healthcare platform jianke.com enters into strategic collaboration with Pfizer MobiHealthNews
Jianke.com, China's online healthcare platform, yesterday announced during the Jianke Doctor Rebrand & 2018 Jianke Partners' Conference in Shanghai that ...
Pfizer and AT&T among companies distancing themselves from Hyde-Smith Daily Mail
Drug companies and tech firms are among those withdrawing support from Republican Cindy Hyde-Smith in the final hours of her Senate runoff as her 'public ...
Oakworth Capital Holding in Pfizer (PFE) Has Trimmed by $2.62 Million as Share Price Rose; Fairfield Bush & Company Upped Intel (INTC) Position The FinExaminer
Oakworth Capital Inc decreased its stake in Pfizer Inc (PFE) by 30.92% based on its latest 2018Q3 regulatory filing with the SEC. Oakworth Capital Inc sold ...
Jones Collombin Investment Counsel Upped Holding in Pfizer (PFE) as Market Valuation Rose; Jlb & Associates Holding in Copart (CPRT) Has Trimmed by $2.21 Million The FinExaminer
Jones Collombin Investment Counsel Inc increased its stake in Pfizer Inc (PFE) by 11.33% based on its latest 2018Q3 regulatory filing with the SEC. Jones Jlb ...
Pfizer publicly announces recall of muscle and menstrual pain wraps it yanked Oct. 2 The State
Pfizer publicly announced Monday a recall of ThermaCare HeatWrap products for muscle pain or menstrual pain that can leak and cause burns or blisters.
Checking the Levels for Pfizer Inc (PFE) Essex Caller
Performance Tracker. Checking in on some recent action on shares of Pfizer Inc (PFE), we can see that the stock price recently touched 44.57. At the open, the ...
Pfizer (PFE) Share Value Rose While Nexus Investment Management Lowered Its Holding by $373,252; Alibaba Group Hldg LTD (BABA) Holder Reliance Trust Lifted Its Stake by $492,328 The FinExaminer
Nexus Investment Management Inc decreased its stake in Pfizer Inc (PFE) by 1.23% based on its latest 2018Q3 regulatory filing with the SEC. Nexus Investment ...
Pfizer recalling heat wrap products Tucson News Now
Pfizer says the products could leak ingredients that are in the heat cell wrap. A leak could cause burns, blisters and skin irritation.
Dow Movers: PFE, INTC Nasdaq
In early trading on Tuesday, shares of Intel Corp ( INTC ) topped the list of the day's best performing Dow Jones Industrial Average components,.
Pfizer wins blockbuster Lyrica patent extension to safeguard sales till June FiercePharma
Pfizer, looking to protect billions in Lyrica sales, has been gunning for a 6-month pediatric exclusivity extension for its top drug. And on Tuesday, the FDA came ...
Pharma giant Pfizer to raise some drug prices Medical Xpress
Pfizer said Friday it would raise US prices on 41 drugs in January, reversing a price freeze implemented over the summer in the face of criticism by President ...
As Pfizer (PFE) Stock Price Rose, Kepos Capital LP Lowered Position; Fuller & Thaler Asset Management Has Lowered Callaway Golf Co (ELY) Position as Stock Price Declined The FinExaminer
Kepos Capital Lp decreased its stake in Pfizer Inc (PFE) by 55.15% based on its latest 2018Q3 regulatory filing with the SEC. Kepos Capital Lp sold 91012 ...
Barry Investment Advisors Has Cut Pfizer (PFE) Holding by $3.08 Million; Stock Price Rose; As Abbvie (ABBV) Valuation Declined, Shareholder Pennsylvania Trust Co Trimmed Stake The FinExaminer
Barry Investment Advisors Llc decreased its stake in Pfizer Inc (PFE) by 24.23% based on its latest 2018Q3 regulatory filing with the SEC. Barry Investment ...
Dodge & Cox Lifted Fedex (FDX) Stake by $495.80 Million; Pfizer (PFE) Stake Boosted by Vantage Investment Advisors Llc The FinExaminer
Dodge & Cox increased its stake in Fedex Corp (FDX) by 20.01% based on its latest 2018Q3 regulatory filing with the SEC. Dodge & Cox bought 2.07 million ...
Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial MarketWatch
Merck KGaA MKKGY, -0.73% and Pfizer Inc. PFE, -1.73% said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a ...
Minus Directional Indicator Seen Above Plus Directional Indicator on Shares of Pfizer Inc. (PFE) Hawthorn Caller
Amateur investors can sometimes become overwhelmed by the speed and volatility of the stock market. Often times, avoiding big mistakes early on can be the.
Beddow Capital Management Has Decreased Its Pfizer (PFE) Holding; Blackrock Muni Intermediate Duration Fund (MUI)'s Sentiment Is 0.84 The FinExaminer
Beddow Capital Management Inc decreased Pfizer Inc (PFE) stake by 8.37% reported in 2018Q3 SEC filing. Beddow Capital Management Inc sold 20555 ...
Better Buy: Pfizer vs. Bristol-Myers Squibb The Motley Fool
Two big pharma stocks. Two potential winners. But which is the better pick for long-term investors?
Nomura Holdings Has Decreased Its Pfizer (PFE) Holding by $22.62 Million; Gmt Capital Has Upped Cigna (CI) Holding by $5.05 Million The FinExaminer
Nomura Holdings Inc decreased its stake in Pfizer Inc (PFE) by 94.99% based on its latest 2018Q3 regulatory filing with the SEC. Nomura Holdings Inc sold Gmt ...
AstraZeneca and Pfizer drugs reimbursed in Australia The Pharma Letter
The Australian government will list new medicines for severe asthma and growth hormone deficiency on its Pharmaceutical Benefits Scheme (PBS).
Wms Partners Maintains Stake in Pfizer (PFE); Btg Pactual Global Asset Management LTD Has Increased Its Stake in Rockwell Collins (COL) by $4.48 Million as Stock Were Volatile The FinExaminer
Wms Partners Llc increased its stake in Pfizer Inc (PFE) by 125.28% based on its latest 2018Q3 regulatory filing with the SEC. Wms Partners Llc bought 31321 ...
Supreme Court dismisses Pfizer's bid for patent protection of pregabalin The Pharmaceutical Journal
The Supreme Court has dismissed a bid by drug company Pfizer to strengthen the patent protection of pregabalin (Lyrica).
Monday?s Vital Data: Pfizer, Goldman Sachs and Caterpillar Investorplace.com
Options trading was buzzing in Pfizer, Goldman Sachs and Caterpillar on Friday. Here are the metrics that matter moving forward.
Organ Transplantation Market Is Booming Worldwide | Leading Key Players (Transonic, TransMedic, Pfizer) Tribune Updates
A new research document is added in HTF MI database of 101 pages, titled as 'Global Organ Transplantation Market Insights by Application, Product Type, ...
Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks.com
Pfizer (PFE) closed the most recent trading day at $44.20, moving +1.57% from the previous trading session.
Genentech and Pfizer Reach Settlement Over Biosimilar Trastuzumab The Center for Biosimilars
Recently, plaintiff Genentech and defendant Pfizer filed a collective stipulation and proposed order of dismissal of a patent infringement lawsuit over ...
Northeast Financial Consultants Has Trimmed Its Pfizer (PFE) Holding; Pimco Income Strategy Fund II (PFN)'s Sentiment Is 1.37 The FinExaminer
Northeast Financial Consultants Inc decreased Pfizer Inc (PFE) stake by 71.16% reported in 2018Q3 SEC filing. Northeast Financial Consultants Inc sold ...
Why Pfizer Amyloidosis Drug Tafamidis Could Lead These 2 Biotech Stocks Rival Treatments Investor's Business Daily
Pfizer amyloidosis drug Tafamidis will get most of the market for the rare disease, with Alnylam and Ionis fighting for the rest, an analyst said.
Viking Fund Management Has Decreased Its Pfizer (PFE) Position by $2.07 Million; Valuation Rose; Mack Cali Rlty (CLI) Holder Clarivest Asset Management Trimmed Holding by $415,800 The FinExaminer
Viking Fund Management Llc decreased its stake in Pfizer Inc (PFE) by 39.83% based on its latest 2018Q3 regulatory filing with the SEC. Viking Fund ...
Pfizer to raise drug prices despite complaints by President Trump FOX 31 Denver
Pfizer is planning to raise prices on 41 drugs in January, a few months after the company agreed to defer hikes under heavy pressure from President Donald ...
Stock Analysis: Focusing on Shares of Pfizer Inc. (PFE) MTL News
Investors may be watching the technical signals on shares of Pfizer Inc. (PFE). Looking at the 50-day moving average vs price signal, the reading is measured at.
Pfizer's Lyrica nabs extra six months of pediatric exclusivity in U.S. Seeking Alpha
The FDA has granted an additional six months of pediatric exclusivity to Pfizer's (PFE +1.2%) LYRICA (pregabalin), extending the period to June 30, 2019.
Pfizer recalls ThermaCare HeatWrap; leakage could cause blisters and burns WJW FOX 8 News Cleveland
Pfizer has issued a voluntary recall of several lots of its ThermaCare HeatWraps. The risk is because of ingredients that could leak from the wrap and cause skin ...
Pfizer reports positive 26-week results from REFLECTIONS B328-06 study Drug Development Technology
Pfizer has reported positive 26-week data from the ongoing REFLECTIONS B328-06 study, a Phase lll trial of PF-05280586 for CD20-positive lymphoma.
Pfizer initiates phase 3 trial of tofacitinib for ankylosing spondylitis Healio
Pfizer has initiated a global phase 3 study intended to evaluate the safety and therapeutic activity of tofacitinib among adult patients with active ankylosing ...
Pfizer Inc. (NYSE:PFE), Aldeyra Therapeutics, Inc. (NasdaqCM:ALDX): Rundown of the Numbers & Valuation Hartsburg News
Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low ...
Global Pediatric Healthcare Market 2018: Abbott, AstraZeneca, GlaxoSmithKline, Merck & Co., Pfizer Journal of Industry
Global Pediatric Healthcare Market has been brewing up and impacting the international economy in terms of growth rate, revenue, sale, market share, and size.
Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity Zacks.com
Pfizer (PFE) receives pediatric exclusivity for its epilepsy drug, Lyrica, extending the exclusivity period to Jun 30, 2019.
Global Nsaids Market 2019- Reddy Pharmaceuticals Ltd, Pfizer Inc, Perrigo Company Journal of Industry
Global Nsaids Market has been brewing up and impacting the international economy in terms of growth rate, revenue, sale, market share, and size. The Global ...
Pfizer Kansas plant hit by FDA 483 with 8 repeat observations BioProcess Insider
The US FDA observed potentialmold contamination and deficient aseptic processes during an inspection at Pfizer's fill/finish facility in McPherson, Kansas.
Global Cetirizine Hydrochloride Market 2019- UCB Pharma, J & J, Pfizer Journal of Industry
Global Cetirizine Hydrochloride Market has been brewing up and impacting the international economy in terms of growth rate, revenue, sale, market share, and ...
Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting Global Banking And Finance Review
Pfizer Inc. (NYSE:PFE) announced today at the American Society of Hematology Annual Meeting that the REFLECTIONS B328-06 study, a comparative safety ...
Analysts Pounding the Pavement on Pfizer Inc. (NYSE:PFE) Bay City Observer
Pfizer Inc. (NYSE:PFE) currently has an A verage Broker Rating of 2.25. This number is based on the 10 sell-side firms polled by Zacks. The ABR rank within.
Pfizer Stock and 3 Other Picks From a Top Growth Fund Barron's
White Oak Select Growth has returned 16% over the past decade. Here's what fund manager Robert Stimpson likes now.
FDA Approves New Cancer Drugs from Pfizer and Loxo Oncology Pharmaceutical Technology Magazine
The agency has approved two new chemical entities, Daurismo (glasdegib) from Pfizer, and Vitrakvi (larotrectinib) from Loxo Oncology, for treating cancers.
Pfizer (PFE) Holder Rfg Advisory Group Lifted Position; Synchrony Finl (SYF) Stock Value Declined While Roystone Capital Management LP Has Upped by $5.93 Million Its Holding The FinExaminer
Rfg Advisory Group Llc increased its stake in Pfizer Inc (PFE) by 23.73% based on its latest 2018Q3 regulatory filing with the SEC. Rfg Advisory Group Llc ...
Why Pfizer Inc. (NYSE:PFE) Has Continued to Shine FDA Headlines
Nov 21, 2018 | Business. Why Pfizer Inc. (NYSE:PFE) Has Continued to Shine. Pfizer Inc. (NYSE:PFE) shares have been sharp outperformers relative to both the ...
Aileron Inks Collaboration Deal With Pfizer for Cancer Combo Zacks.com
Aileron Therapeutics (ALRN) signs a clinical trial collaboration contract with Pfizer to study the combo of Aileron's ALRN-6924 and Pfizer's Ibrance for treating ...
Pfizer to raise prices on 41 drugs despite earlier deferral on price hikes MedCity News
Despite putting on hold a plan to increase prices on a host of its drugs, Pfizer said it will nevertheless raise prices on more than three dozen in January.
Allergan says tossing Pfizer lawsuit could endanger potential opioid accord Reuters
Allergan PLC says the chances of reaching a global settlement in the federal opioid litigation could be jeopardized if a judge dismisses a lawsuit seeking to force ...
Lawmaker chastises Pfizer for reverting to price hikes next month STAT
Sen. Tammy Baldwin chastised Pfizer for ?playing political games? with price hikes and failing to answers questions about freezes made in July.
Stocks to watch: WPP, 888, Pfizer, Aviva, Standard Life, BASF, Total Financial Times
Superdry's turnround may require another year of clearance sales, says Berenberg.
UK Supreme Court rules against Pfizer in landmark second medical use patent case Zenopa
The Supreme Court has now agreed that patent claims relevant to the neuropathic pain indications are invalid.
New England Professional Planning Group Holding in Pfizer (PFE) Has Decreased by $338,712 as Shares Rose; Microsoft (MSFT) Stock Price Declined While Glaxis Capital Management Lowered Stake by $4.18 Million The FinExaminer
New England Professional Planning Group Inc decreased its stake in Pfizer Inc (PFE) by 3.43% based on its latest 2018Q3 regulatory filing with the SEC.
Carlos Ghosn, Apple, US-China Trade, Bitcoin and Pfizer - 5 Things You Must Know TheStreet.com
Reports suggest Renault CEO Carlos Ghosn faces arrest in Japan after Nissan said he had misused company funds and will be ousted as chairman; Apple is ...